ISSN:
1573-7217
Schlagwort(e):
adjuvant treatment
;
breast cancer
;
chemotherapy
;
immunotherapy
;
radiotherapy
;
randomized trial
Quelle:
Springer Online Journal Archives 1860-2000
Thema:
Medizin
Notizen:
Abstract With a median follow-up of 14 years, the combination of polyadenylic–polyuridylic acid plus locoregional radiotherapy (257 patients) has significantly improved disease-free survival (p = 0.03) and significantly reduced the incidence of metastases (p = 0.04) when compared to CMF alone (260 patients), in women with operable breast cancer. The trial does not, however, permit an appreciation of the respective role of radiotherapy and PolyAU in these results.
Materialart:
Digitale Medien
URL:
http://dx.doi.org/10.1023/A:1006498121628
Permalink